| Literature DB >> 34957347 |
Muhammad Ayub1, Mohd Hafiz Dzarfan Othman1, Imran Ullah Khan2, Mohd Zamri Mohd Yusop1, Tonni Agustiono Kurniawan3.
Abstract
The recently emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a significant and topmost global health challenge of today. SARS-CoV-2 can propagate through several direct or indirect means resulting in its exponential spread in short times. Consequently, finding new research based real-world and feasible solutions to interrupt the spread of pathogenic microorganisms is indispensable. It has been established that this virus can survive on a variety of available surfaces ranging from a few hours to a few days, which has increased the risk of COVID-19 spread to large populations. Currently, available surface disinfectant chemicals provide only a temporary solution and are not recommended to be used in the long run due to their toxicity and irritation. Apart from the urgent development of vaccine and antiviral drugs, there is also a need to design and develop surface disinfectant antiviral coatings for long-term applications even for new variants. The unique physicochemical properties of graphene-based nanomaterials (GBNs) have been widely investigated for antimicrobial applications. However, the research work for their use in antimicrobial surface coatings is minimal. This perspective enlightens the scope of using GBNs as antimicrobial/antiviral surface coatings to reduce the spread of transmittable microorganisms, precisely, SARS-CoV-2. This study attempts to demonstrate the synergistic effect of GBNs and metallic nanoparticles (MNPs), for their potential antiviral applications in the development of surface disinfectant coatings. Some proposed mechanisms for the antiviral activity of the graphene family against SARS-CoV-2 has also been explained. It is anticipated that this study will potentially lead to new insights and future trends to develop a framework for further investigation on this research area of pivotal importance to minimize the transmission of current and any future viral outbreaks.Entities:
Keywords: Antimicrobial; COVID-19; Disinfectant; Graphene; Surface coatings
Year: 2021 PMID: 34957347 PMCID: PMC8442307 DOI: 10.1016/j.surfin.2021.101460
Source DB: PubMed Journal: Surf Interfaces ISSN: 2468-0230
Fig. 1(A) Comparison of research work on SARS-CoV-2 for vaccines/drugs and surface disinfection/killing procedures [60], [61] (B) Number of research articles for antimicrobial activity of graphene [11].
Epidemiological characteristics of three coronavirus diseases.
| Disease typeParameters | Severe acute respiratory syndrome (SARS CoV-1) | Middle East respiratory syndrome (MERS) | Severe acute respiratory syndrome 2 (SARS CoV-2) | References |
|---|---|---|---|---|
| Reporting year | 2002 | 2012 | 2019 | |
| Origin country | China | Saudi Arabia | China | |
| Transmission and source | human to human | human to human infected camel to human | human to human | |
| Transmission through | respiratory secretions | respiratory secretions | respiratory secretions virus contaminated surface touch | |
| Total countries affected | 32 | 27 | 217 ↑ | |
| Confirmed cases | 8098 | 2494, 2519 | 54,075,995 ↑ | |
| Fatality ratio | 14–15% | 34.4% - 35% | 3.4 ↑ | |
| Total deaths reported | 813 | 858 | 1231,017 ↑ | |
| Symptoms | fever (>38 °C), chills and rigors headache, malaise, and muscle pain | fever, cough, and shortness of breath, septic shock, Pneumonia, multiple organ failure, or asymptomatic | Fever, dry cough, tiredness, difficulty breathing, chest pain, sore throat, loss of taste and smell, or asymptomatic | |
| Prevention | isolation, tracing, quarantine 10 days, screening, disinfection of aircraft and cruise vessels | avoiding contact with camels and sick persons | frequent hand wash, social distance, avoid touching surfaces and face, cover mouth and nose, stay home, quarantine 14 days | |
| Treatment (Vaccines) | >200 under development Still no vaccine in market |
Fig. 2Comparison of the stability of SARS CoV-2 on various surfaces at ambient temperature.
Fig. 3FESEM images of GO nanosheets (a) and RGO nanosheets (b) [76].
Fig. 4Three principal mechanisms of antimicrobial materials on various surfaces [66].
Comparison of antiviral activity of the graphene family members against a broad range of viruses.
| Virus family | Target Virus name | Nucleic acid | Viral envelope | GBNs used | Ref |
|---|---|---|---|---|---|
| Coronaviridae | PEDV | RNA | Enveloped | GO-PVP, C-dots | |
| Coronaviridae | FCoV | RNA | Enveloped | GO-AgNPs | |
| Leviviridae | MS2 bacteriophage | RNA | Non- Enveloped | GO, fullerene | |
| Birnaviridae | IBDV | RNA | Non- Enveloped | GO-AgNPs | |
| Arteriviridae | PRRSV | RNA | Enveloped | Go-AgNPs, C-dots | |
| Rhabdoviridae | VSV, | RNA | Enveloped | GO | |
| Retroviridae | HIV, | RNA | Enveloped | Graphene, Fullerene | |
| Reoviridae | NDRV, | RNA | Non- enveloped | GO/HY | |
| Pneumoviridae | RSV | RNA | Enveloped | GO, Fullerene | |
| Herpesviridae | SuHV-1 (PRV) | DNA | Enveloped | GO, C-dots |
Fig. 5(A) Anti-viral and antibacterial activity of GO (A) plaque-reduction assay for PRV infected cells with and without using GO (B) Indirect immunofluorescence assay of PRV infected cells in the presence and absence of GO [29], (C) SEM images showing the destruction of E. coli and S. aureus grown onto Cu, Ge and SiO2 deposited graphene films [127]. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 6(A) Various reported graphene derivatives for SARS-CoV-2 inactivation [12] (B) Schematic illustration showing antiviral properties and inactivation mechanisms of SARS-CoV-2 on GBNs coated surfaces.